Stem Cell Therapy For Fibromyalgia
Stem Cell Therapy For Fibromyalgia
Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and heightened sensitivity to pain.
Key features of fibromyalgia include:
1. Widespread pain: The hallmark symptom of fibromyalgia is chronic, widespread pain that affects multiple areas of the body, including both sides and above and below the waist. The pain can be described as aching, burning, or throbbing and may vary in intensity.
2. Tender points: People with fibromyalgia may have specific tender points on the body that are particularly sensitive to pressure. These tender points are located at specific anatomical sites and are used as part of the diagnostic criteria for the condition.
3. Fatigue: Persistent fatigue is a common symptom of fibromyalgia, and individuals may experience reduced energy levels and a sense of tiredness even after restful sleep.
4. Sleep disturbances: Many people with fibromyalgia have difficulties with sleep, including trouble falling asleep, staying asleep, or waking up feeling unrefreshed.
5. Cognitive difficulties: Some individuals with fibromyalgia may experience cognitive issues often referred to as "fibro fog." This can include problems with memory, concentration, and mental clarity.
6. Other symptoms: Fibromyalgia can be associated with a range of other symptoms, such as headaches, irritable bowel syndrome (IBS), temporomandibular joint disorder (TMJ), anxiety, and depression.
The exact cause of fibromyalgia is not fully understood, but it is believed to involve a combination of genetic, environmental, and neurological factors. Diagnosis is typically made based on a patient's medical history, physical examination, and the presence of specific symptoms.
Currently, various treatments and management strategies aim to alleviate symptoms and improve quality of life. These may include medication, stem cells,physical therapy, cognitive-behavioral therapy (CBT), exercise, and stress management techniques.
Key features of fibromyalgia include:
1. Widespread pain: The hallmark symptom of fibromyalgia is chronic, widespread pain that affects multiple areas of the body, including both sides and above and below the waist. The pain can be described as aching, burning, or throbbing and may vary in intensity.
2. Tender points: People with fibromyalgia may have specific tender points on the body that are particularly sensitive to pressure. These tender points are located at specific anatomical sites and are used as part of the diagnostic criteria for the condition.
3. Fatigue: Persistent fatigue is a common symptom of fibromyalgia, and individuals may experience reduced energy levels and a sense of tiredness even after restful sleep.
4. Sleep disturbances: Many people with fibromyalgia have difficulties with sleep, including trouble falling asleep, staying asleep, or waking up feeling unrefreshed.
5. Cognitive difficulties: Some individuals with fibromyalgia may experience cognitive issues often referred to as "fibro fog." This can include problems with memory, concentration, and mental clarity.
6. Other symptoms: Fibromyalgia can be associated with a range of other symptoms, such as headaches, irritable bowel syndrome (IBS), temporomandibular joint disorder (TMJ), anxiety, and depression.
The exact cause of fibromyalgia is not fully understood, but it is believed to involve a combination of genetic, environmental, and neurological factors. Diagnosis is typically made based on a patient's medical history, physical examination, and the presence of specific symptoms.
Currently, various treatments and management strategies aim to alleviate symptoms and improve quality of life. These may include medication, stem cells,physical therapy, cognitive-behavioral therapy (CBT), exercise, and stress management techniques.
What may this include:
- Medical Consultation
- 50 Mm Msc Iv
- 250 Mm Mcs Iv
- 30 Mc Exosomes Iv
- Multivitamins Iv
- Post therapy diet
References
1.Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK. Decreased Central μ-Opioid Receptor Availability in Fibromyalgia. J Neurosci. 2007 Sep 5;27(36):10000-10006. doi: 10.1523/JNEUROSCI.2849-07.2007. PMID: 17804628; PMCID: PMC6670888.
2.Kim HJ, Jeong YH, Lee SH, Kim KN, Kim SY, Hong YH. Therapeutic effects of adipose-derived stem cells pretreated with pioglitazone in an experimental model of fibromyalgia. Stem Cell Res Ther. 2019 Jan 10;10(1):18. doi: 10.1186/s13287-018-1121-4. PMID: 30630534; PMCID: PMC6326888.
3.Lee JH, Oh SH, Cho HS, Kim YK. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int Immunopharmacol. 2012 Mar;12(3):657-66. doi: 10.1016/j.intimp.2012.01.010. Epub 2012 Jan 20. PMID: 22285203.
1.Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK. Decreased Central μ-Opioid Receptor Availability in Fibromyalgia. J Neurosci. 2007 Sep 5;27(36):10000-10006. doi: 10.1523/JNEUROSCI.2849-07.2007. PMID: 17804628; PMCID: PMC6670888.
2.Kim HJ, Jeong YH, Lee SH, Kim KN, Kim SY, Hong YH. Therapeutic effects of adipose-derived stem cells pretreated with pioglitazone in an experimental model of fibromyalgia. Stem Cell Res Ther. 2019 Jan 10;10(1):18. doi: 10.1186/s13287-018-1121-4. PMID: 30630534; PMCID: PMC6326888.
3.Lee JH, Oh SH, Cho HS, Kim YK. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int Immunopharmacol. 2012 Mar;12(3):657-66. doi: 10.1016/j.intimp.2012.01.010. Epub 2012 Jan 20. PMID: 22285203.